A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61P 25/30 (2006.01) A61P 25/32 (2006.01) A61P 25/34 (2006.01) A61P 25/36 (2006.01)
Patent
CA 2575848
The invention relates to the use of a molecule either alone or in a combination selected from the group of molecules having a simultaneous antagonist action on alpha-noradrenergic, NMDA glutamatergic and 5HT2 serotoninergic receptors, for the preparation of a medicament that is intended for the treatment of central nervous system pathologies.
L'invention concerne l'utilisation d'une molécule seule ou en une combinaison choisie dans le groupe des molécules ayant une action antagoniste simultanée sur les récepteurs alphal-noradrénergiques, NMDA glutamatergiques et 5HT2 sérotoninergiques, pour la préparation d'un médicament destiné à traiter les pathologies du système nerveux central .
Bernard Philippe
Trovero Fabrice
Greenpharma
Key Obs
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Medicament for the treatment of central nervous system... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament for the treatment of central nervous system..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for the treatment of central nervous system... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1854377